Sign in
Taking peopleNo phase

Optimising Antibiotic Use for Paediatric Lower Respiratory Tract Infections in Africa

Key facts

Who runs it
University of Witwatersrand, South Africa
Where
South Africa1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
400 people, planned
Started
27 May 2026
Expected to end
30 Jun 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • CRP- and PREPARE-guided Antibiotic Prescription
Record updated
25 September 2026

Who can take part

Age
2 months to 24 months
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Children between the ages of 2-24 months
  • Clinician diagnosis of lower respiratory tract infection (LRTI)

Who cannot take part

  • Transferred from other hospitals with more than 24 hours of hospitalisation
  • Hospitalisation within the preceding 30 days

This trial is currently available in South Africa.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Lower respiratory tract infections (LRTIs) remain a leading cause of hospitalisation and death among young children in Africa. Although viral infections account for a substantial proportion of LRTIs, antibiotics are frequently prescribed because distinguishing between viral and bacterial infections can be challenging. This contributes to unnecessary antibiotic exposure and the rising global public health challenge of antimicrobial resistance.

Read full original descriptionShow less

This pragmatic, unblinded randomised controlled study will evaluate whether the combination of point-of-care (POC) C-reactive protein (CRP) testing and the PREPARE clinical severity score can safely reduce antibiotic use among children aged 2 to 24 months hospitalised with LRTI at Chris Hani Baragwanath Academic Hospital (CHBAH), South Africa. Participants will be randomly assigned in a 1:1 ratio to either the intervention group, where antibiotic decisions are guided by serial POC CRP measurements and repeated PREPARE severity assessments, or a control group receiving routine clinical care.

The primary objective of the study is to compare antibiotic use during hospitalisation between the intervention and control groups. Secondary objectives are to evaluate the safety of this approach by comparing mortality, hospital readmission within 28 days, adverse events, need for invasive ventilation, duration of hospitalisation, and other clinical outcomes between study groups. In addition, the study will compare healthcare-related costs, including antibiotic expenditure and costs associated with hospitalisation.

A parallel mixed-methods component will explore clinician attitudes, beliefs, and determinants of antibiotic prescribing for children hospitalised with LRTI using surveys, focus groups discussions, and individual interviews informed by the Theoretical Domains Framework (TDF). Findings will help identify behavioural and system-level factors that influence antibiotic prescribing and inform future antimicrobial stewardship interventions.

This study aims to generate evidence on whether biomarker-guided and risk-stratified care can safely optimise antibiotic use among young African children hospitalised with LRTI while improving antimicrobial stewardship and reducing healthcare costs.

The 2 groups in the trial

  • Intervention arm: CRP- and PREPARE-Guided Antibiotic UseTreatment being tested

    Participants will receive antibiotic prescribing guidance based on serial point-of-care CRP measurements and repeated PREPARE clinical severity score assessments in addition to routine clinical care.

    Treatment: CRP- and PREPARE-guided Antibiotic Prescription

  • Control: Standard of CareNo study treatment, for comparison

    Participants will receive routine clinical management according to existing hospital and unit-specific practice. Antibiotic prescribing decisions will be made by the treating clinical team without guidance from the study intervention, including point-of-care CRP testing and the PREPARE clinical severity score algorithm

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Optimising Antibiotic Use for Young African Children Hospitalised With Lower Respiratory Tract Infections: the Role of Biomarkers, Clinical Severity Scoring and Clinician Attitudes
Record updated
25 September 2026